CHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 9 | 2011 | 4161 | 4408 | 94.4% | |
| CHD 9 | 2012 | 4101 | 4377 | 93.7% | |
| CHD 9 | 2013 | 4042 | 4335 | 93.2% | |
| CHD005 | 2014 | 3991 | 4197 | 95.1% | |
| CHD005 | 2015 | 3959 | 4134 | 95.8% | |
| CHD005 | 2016 | 3940 | 4129 | 95.4% | |
| CHD005 | 2017 | 3968 | 4084 | 97.2% | |
| CHD005 | 2018 | 3873 | 4030 | 96.1% | |
| CHD005 | 2019 | 3872 | 3983 | 97.2% | |
| CHD005 | 2020 | 3858 | 4085 | 94.4% | |
| CHD005 | 2021 | 3738 | 4168 | 89.7% | |
| CHD005 | 2022 | 3854 | 4100 | 94.0% | |
| CHD005 | 2023 | 3925 | 4068 | 96.5% |
